Harvard Bioscience, Inc. übernimmt AHN Biotechnologie GmbH (Kopie 1)
Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has acquired the business of AHN Biotechnologie GmbH through a subsidiary of its wholly owned Biochrom Ltd. subsidiary.
AHN Biotechnologie GmbH is a privately held manufacturer of plastic consumable laboratory products including pipette tips.
Harvard Bioscience is developing, manufacturing and marketing a broad range of specialized products, primarily apparatus and scientific instruments, used to advance life science research and regenerative medicine. Harvard Bioscience sells products to thousands of researchers in over 100 countries. Harvard Bioscience has sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden and Spain with additional facilities in France and Canada. For more information, please see www.harvardbioscience.com.
This acquisition is complementary to the current Biochrom Ltd. product line of molecular biology instruments. It gives Harvard Bioscience a base of business in Germany for its entire molecular biology business.
In Germany, Harvard Bioscience was advised by Graf von Westphalen, in the US by Damon Morey LLP.
Advisors Harvard Bioscience, Inc.:
Graf von Westphalen (Frankfurt): Florian Wolff, Dr Marco Zessel (both Corporate M&A). Damon Morey (Buffalo, New York, USA): Gust Pullman (M&A)
News
Federal Administrative Court: Fehmarn Belt Fixed Link may be built
The Federal Administrative Court has dismissed all six pending appeals against the planning decision on the Fehmarn Belt Fixed Link. Construction of the tunnel may therefore now also begin in Germany. GvW advised the State of Schleswig-Holstein and was represented by a Hamburg team consisting of Dr Ronald Steiling (lead), Corinna Lindau, Dr Dietrich Drömann, Prof. Dr Christian Winterhoff, Dr Andreas Wolowski, Saskia Soravia, Dr Stefanie Ramsauer, Dr Annika Bleier, Felix Kazimierski and Niclas Langhans. (BVerwG 9 A 6.19, 9 A 7.19, 9 A 9.19, 9 A 10.19, 9 A 11.19, 9 A 12.19 and 9 A 13.19).
H4 Hotel Mönchengladbach at BORUSSIA-PARK: the place for that Bundesliga feeling
Football is king at H-Hotel Group’s new H4 Hotel in Mönchengladbach. Its location right next to the stadium and the theme rooms depicting the history of the Borussia Dortmund football club make this new hotel unique and a must for any football enthusiast. Our lawyers had the pleasure of advising H-Hotels Group on the creation of its first football-themed hotel and took the chance to visit this amazing place shortly after its opening.
Transport System Bögl: new local public passenger transport system a big success in China
The Max Bögl group of companies has developed a new local public passenger transport system. The system called “Transport System Bögl” (TSB) uses magnetic levitation, or “maglev” technology and provides a clean and cost-efficient means of transport for better mobility in inner city areas. The technology is becoming increasingly popular also in other countries: Max Bögl’s most recent export order was the sale of its TSB to China. The company’s plans include building a 3.5 km test track in Chengdu and extensive marketing activities to promote the technology in China – all through a sales partnership with a Chinese company.
You don't want to miss any more of the latest legal developments? And be invited to our events? Then register here.